M. S. Marriott
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility
Papers in
-
- Antifungal resistance and susceptibility 11
-
- Glycosylation and Glycoproteins Research 3
- Enzyme Catalysis and Immobilization 3
- Microbial Metabolic Engineering and Bioproduction 3
- Co-authors
- Kenneth Richardson (6 shared papers)Peter F. Troke (5 shared papers)S. G. B. Amyes (4 shared papers)K. W. Brammer (4 shared papers)R. J. Andrews (2 shared papers)Michael H. Tarbit (5 shared papers)Keith Cooper (2 shared papers)Widmar Tanner (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)Journal of Antimicrobial Chemotherapy (3 papers)Annals of the New York Academy of Sciences (2 papers)Journal of Medicinal Chemistry (1 paper)Expert Opinion on Investigational Drugs (1 paper)
- Partner nations
- United KingdomUnited StatesSouth Africa
In The Last Decade
M. S. Marriott
32 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 99
- Molecular Medicine 172
- Infectious Diseases 485
- Applied Microbiology and Biotechnology 26
- Pharmacology 198
- Epidemiology 346
Countries citing papers authored by M. S. Marriott
This map shows the geographic impact of M. S. Marriott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. S. Marriott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. S. Marriott more than expected).
Fields of papers citing papers by M. S. Marriott
This network shows the impact of papers produced by M. S. Marriott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. S. Marriott. The network helps show where M. S. Marriott may publish in the future.
Co-authors
The 25 scholars most cited alongside M. S. Marriott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 148 | |
| 2 | 1985 | 143 | |
| 3 | 1998 | 100 | |
| 4 | 1990 | 99 | |
| 5 | 1975 | 89 | |
| 6 | 1985 | 86 | |
| 7 | 1980 | 81 | |
| 8 | 1998 | 70 | |
| 9 | 1987 | 56 | |
| 10 | 1979 | 41 | |
| 11 | 1975 | 38 | |
| 12 | 1982 | 36 | |
| 13 | 1988 | 35 | |
| 14 | 1988 | 28 | |
| 15 | 1977 | 21 | |
| 16 | 1993 | 19 | |
| 17 | 1989 | 19 | |
| 18 | 1977 | 19 | |
| 19 | 1997 | 14 | |
| 20 | 1989 | 13 |
About M. S. Marriott
M. S. Marriott is a scholar working on Infectious Diseases, Molecular Biology, Epidemiology, Organic Chemistry and Molecular Medicine, having authored 33 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (11 papers), Antibiotic Resistance in Bacteria (5 papers), Fungal Infections and Studies (4 papers), Carbohydrate Chemistry and Synthesis (4 papers), Glycosylation and Glycoproteins Research (3 papers), Enzyme Catalysis and Immobilization (3 papers), Nail Diseases and Treatments (3 papers) and Microbial Metabolic Engineering and Bioproduction (3 papers). The work is most often cited by research in Molecular Medicine (172 citations), Infectious Diseases (485 citations), Applied Microbiology and Biotechnology (26 citations), Pharmacology (198 citations) and Epidemiology (346 citations). M. S. Marriott has collaborated with scholars based in United Kingdom, United States and South Africa. Frequent co-authors include Kenneth Richardson, Peter F. Troke, S. G. B. Amyes, K. W. Brammer, R. J. Andrews, Michael H. Tarbit, Keith Cooper, Widmar Tanner, P. J. WHITTLE and O. S. KINSMAN. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and Expert Opinion on Investigational Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.